Camilla Engblom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Camilla Engblom has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Jens Lagergren
KTH Royal Institute of Technology
6 shared publications - Johan Hartman
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
6 shared publications - Xinsong Chen
Karolinska Institutet
6 shared publications - Joakim Lundeberg
Department of Gene Technology, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden
5 shared publications - Eduardo J. Villablanca
Karolinska Institutet and University Hospital
4 shared publications Hosein Toosi
SciLifeLab, School of EECS, KTH Royal Institute of Technology, Stockholm, Sweden
4 shared publications
Latest Publications
- Open Access
- 10 July 2026
- Published by Elsevier in Current Opinion in Immunology
- Vol. 102, 102816
Mapping antibody sequences and effector functions across spatial niches
- 10 July 2026
- Published by Elsevier in Current Opinion in Immunology
- Vol. 102, 102816
Open AccessMapping antibody sequences and effector functions across spatial niches
- Open Access
- 7 April 2026
- Published by Wiley in European Journal of Immunology
- Vol. 56 (4) , e70185
Uncovering Immune Niches in Health and Disease Using Spatial Transcriptomics
Spatial transcriptomics allows for the investigation of complex cellular ecosystems directly in their native tissues and enables the dissection of immune niches as spatially organized and functionally diverse microenvironments across homeostatic, inflammatory, and malignant settings. In this review, we examine how spatial transcriptomics tools have been applied to interrogate the cellular and molecular architecture of immune niches, including the emerging studies of B and T cell clonal niches. We focus on immune niches in intestinal and tumor tissues due to their importance to both health and pathology, discuss pressing immunological questions these technologies may help to address, and highlight future developments in the field.
- 7 April 2026
- Published by Wiley in European Journal of Immunology
- Vol. 56 (4) , e70185
Open AccessUncovering Immune Niches in Health and Disease Using Spatial Transcriptomics
Spatial transcriptomics allows for the investigation of complex cellular ecosystems directly in their native tissues and enables the dissection of immune niches as spatially organized and functionally diverse microenvironments across homeostatic, inflammatory, and malignant settings. In this review, we examine how spatial transcriptomics tools have been applied to interrogate the cellular and molecular architecture of immune niches, including the emerging studies of B and T cell clonal niches. We focus on immune niches in intestinal and tumor tissues due to their importance to both health and pathology, discuss pressing immunological questions these technologies may help to address, and highlight future developments in the field.
- 14 April 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 43 (4) , 471-476
Putting cancer immunotherapy into spatial context in the clinic
- 14 April 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 43 (4) , 471-476
Putting cancer immunotherapy into spatial context in the clinic
- Open Access
- 21 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1
Author Correction: Integrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope
- 21 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1
Open AccessAuthor Correction: Integrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope
- Open Access
- 29 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Integrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope
Spatial and genomic heterogeneity of tumors are crucial factors influencing cancer progression, treatment, and survival. However, a technology for direct mapping the clones in the tumor tissue based on somatic point mutations is lacking. Here, we propose Tumoroscope, the first probabilistic model that accurately infers cancer clones and their localization in close to single-cell resolution by integrating pathological images, whole exome sequencing, and spatial transcriptomics data. In contrast to previous methods, Tumoroscope explicitly addresses the problem of deconvoluting the proportions of clones in spatial transcriptomics spots. Applied to a reference prostate cancer dataset and a newly generated breast cancer dataset, Tumoroscope reveals spatial patterns of clone colocalization and mutual exclusion in sub-areas of the tumor tissue. We further infer clone-specific gene expression levels and the most highly expressed genes for each clone. In summary, Tumoroscope enables an integrated study of the spatial, genomic, and phenotypic organization of tumors.
- 29 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Open AccessIntegrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope
Spatial and genomic heterogeneity of tumors are crucial factors influencing cancer progression, treatment, and survival. However, a technology for direct mapping the clones in the tumor tissue based on somatic point mutations is lacking. Here, we propose Tumoroscope, the first probabilistic model that accurately infers cancer clones and their localization in close to single-cell resolution by integrating pathological images, whole exome sequencing, and spatial transcriptomics data. In contrast to previous methods, Tumoroscope explicitly addresses the problem of deconvoluting the proportions of clones in spatial transcriptomics spots. Applied to a reference prostate cancer dataset and a newly generated breast cancer dataset, Tumoroscope reveals spatial patterns of clone colocalization and mutual exclusion in sub-areas of the tumor tissue. We further infer clone-specific gene expression levels and the most highly expressed genes for each clone. In summary, Tumoroscope enables an integrated study of the spatial, genomic, and phenotypic organization of tumors.
- 29 July 2024
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 24 (9) , 617
Location matters: mapping antigen receptors within tissues
- 29 July 2024
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 24 (9) , 617
Location matters: mapping antigen receptors within tissues
- 8 December 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 382 (6675) , 1137-+
Spatial transcriptomics of B cell and T cell receptors reveals lymphocyte clonal dynamics
The spatial distribution of lymphocyte clones within tissues is critical to their development, selection, and expansion. We have developed spatial transcriptomics of variable, diversity, and joining (VDJ) sequences (Spatial VDJ), a method that maps B cell and T cell receptor sequences in human tissue sections. Spatial VDJ captures lymphocyte clones that match canonical B and T cell distributions and amplifies clonal sequences confirmed by orthogonal methods. We found spatial congruency between paired receptor chains, developed a computational framework to predict receptor pairs, and linked the expansion of distinct B cell clones to different tumor-associated gene expression programs. Spatial VDJ delineates B cell clonal diversity and lineage trajectories within their anatomical niche. Thus, Spatial VDJ captures lymphocyte spatial clonal architecture across tissues, providing a platform to harness clonal sequences for therapy.
- 8 December 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 382 (6675) , 1137-+
Spatial transcriptomics of B cell and T cell receptors reveals lymphocyte clonal dynamics
The spatial distribution of lymphocyte clones within tissues is critical to their development, selection, and expansion. We have developed spatial transcriptomics of variable, diversity, and joining (VDJ) sequences (Spatial VDJ), a method that maps B cell and T cell receptor sequences in human tissue sections. Spatial VDJ captures lymphocyte clones that match canonical B and T cell distributions and amplifies clonal sequences confirmed by orthogonal methods. We found spatial congruency between paired receptor chains, developed a computational framework to predict receptor pairs, and linked the expansion of distinct B cell clones to different tumor-associated gene expression programs. Spatial VDJ delineates B cell clonal diversity and lineage trajectories within their anatomical niche. Thus, Spatial VDJ captures lymphocyte spatial clonal architecture across tissues, providing a platform to harness clonal sequences for therapy.
- Open Access
- 22 February 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics
Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer’s proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from single-cell RNA sequencing data to reconstruct high-fidelity clonal trees. We evaluate PhylEx on synthetic and well-characterized high-grade serous ovarian cancer cell line datasets. PhylEx outperforms the state-of-the-art methods both when comparing capacity for clonal tree reconstruction and for identifying clones. We analyze high-grade serous ovarian cancer and breast cancer data to show that PhylEx exploits clonal expression profiles beyond what is possible with expression-based clustering methods and clear the way for accurate inference of clonal trees and robust phylo-phenotypic analysis of cancer.
- 22 February 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Open AccessReconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics
Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer’s proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from single-cell RNA sequencing data to reconstruct high-fidelity clonal trees. We evaluate PhylEx on synthetic and well-characterized high-grade serous ovarian cancer cell line datasets. PhylEx outperforms the state-of-the-art methods both when comparing capacity for clonal tree reconstruction and for identifying clones. We analyze high-grade serous ovarian cancer and breast cancer data to show that PhylEx exploits clonal expression profiles beyond what is possible with expression-based clustering methods and clear the way for accurate inference of clonal trees and robust phylo-phenotypic analysis of cancer.
- Open Access
B cell expansion hinders the stroma-epithelium regenerative cross talk during mucosal healing
- Open Access
Spatial transcriptomics of T and B cell receptors uncovers lymphocyte clonal dynamics in human tissue
The spatial distribution of lymphocyte clones within tissues is critical to their development, selection, and expansion. We have developed Spatial Transcriptomics of VDJ sequences (Spatial VDJ), which maps immunoglobulin and TR antigen receptors in human tissue sections. Spatial VDJ captures lymphocyte clones matching canonical T, B, and plasma cell distributions in tissues and amplifies clonal sequences confirmed by orthogonal methods. We confirm spatial congruency between paired receptor chains, develop a computational framework to predict receptor pairs, and link the expansion of distinct B cell clones to different tumor-associated gene expression programs. Spatial VDJ delineates B cell clonal diversity, class switch recombination, and lineage trajectories within their spatial context. Taken together, Spatial VDJ captures lymphocyte spatial clonal architecture across tissues, which could have important therapeutic implications. One-Sentence Summary: Spatial transcriptomics-based technology co-captures T and B cell receptors within their anatomical niche in human tissue.
Open AccessSpatial transcriptomics of T and B cell receptors uncovers lymphocyte clonal dynamics in human tissue
The spatial distribution of lymphocyte clones within tissues is critical to their development, selection, and expansion. We have developed Spatial Transcriptomics of VDJ sequences (Spatial VDJ), which maps immunoglobulin and TR antigen receptors in human tissue sections. Spatial VDJ captures lymphocyte clones matching canonical T, B, and plasma cell distributions in tissues and amplifies clonal sequences confirmed by orthogonal methods. We confirm spatial congruency between paired receptor chains, develop a computational framework to predict receptor pairs, and link the expansion of distinct B cell clones to different tumor-associated gene expression programs. Spatial VDJ delineates B cell clonal diversity, class switch recombination, and lineage trajectories within their spatial context. Taken together, Spatial VDJ captures lymphocyte spatial clonal architecture across tissues, which could have important therapeutic implications. One-Sentence Summary: Spatial transcriptomics-based technology co-captures T and B cell receptors within their anatomical niche in human tissue.